Pharmaceuticals / Biotechnology

Strategy for the whole development journey.

From lead candidate selection through first-in-human and later-stage studies, to registration.

Our Approach

Operational advice grounded in your clinical intentions.

EdGe Toxicology draws on extensive experience to help clients plan and execute their development programmes. That support can be specific to a select stage of development, or an integrated development plan for the whole product; from lead candidate selection, through first-in-human and later-stage clinical studies, to registration.

Disciplines & therapeutic areas.

We operate across a variety of disciplines and therapeutic routes; including, and not limited to, the following.

DISCIPLINES INCLUDE:

Small molecular entities

Vaccines & biologicals

Combination products

And more

THERAPEUTIC AREAS INCLUDE:

Oncology

CNS

Cardiovascular

Anti-infectives

Ocular

Dermal

And more

Don't see your discipline or therapeutic area listed? Chances are we've worked in it. Get in touch and let's talk.

Examples of our work

What we deliver.

Our work spans the practical and regulatory demands of nonclinical development, from study oversight through to submission-ready documentation. We provide experienced, flexible support that helps programmes stay on track, resolve issues efficiently and meet regulatory expectations.

Study monitoring & coordination

Acting as your single point of contact for outsourced studies. Interpreting results, contingency planning and troubleshooting, report review, and summarisation and integration into regulatory documents.

Regulatory writing

Nonclinical documentation for regulatory submissions at clinical trial and marketing authorisation stages.

Impurity & excipient assessment

Toxicological assessments of impurities and excipients according to ICH Q3D, ICH Q3C and ICH M7.